Publications by authors named "Maria Michela Scirocco"

We conducted a real-life case-control study among outpatients with Omicron SARS-CoV-2 infection to assess the effectiveness of molnupiravir (MNP) in reducing hospital admission, admission to the intensive care unit, and death at day 28. Cases were SARS-CoV-2-positive patients seeking medical care within five days of symptom onset from 1 January to 31 December 2022, who received MNP. Controls were selected from a regional database among positive subjects who did not receive antiviral treatment for SARS-CoV-2.

View Article and Find Full Text PDF

Background: Ritonavir-boosted nirmatrelvir (N/r) is an antiviral which targets the main viral protease, administered to prevent the progression of SARS-CoV-2 infection in patients at high risk for severe COVID-19. We present a real-life case-control study evaluating the efficacy of N/r therapy in SARS-CoV-2 omicron variants positive outpatients in Campania region, Italy, with the aim of assessing the occurrence of three outcomes (hospital admission, admission in ICU and death) in cases and controls.

Methods: We enrolled SARS-CoV-2 positive subjects that came to our attention in Early antiviral treatment ambulatory of Infectious Diseases ward of University Federico II of Naples, Italy from January 1st, 2022, to December 31st, 2022, during the first five days from symptoms occurrence.

View Article and Find Full Text PDF
Article Synopsis
  • Spondylodiscitis is a rare condition with limited treatment options, requiring long-term therapy, typically lasting up to twelve months, and azoles are the only available oral treatment for home therapy.
  • The case study reports a 68-year-old paraplegic patient who experienced reduced efficacy from azole treatment and was successfully treated with 200 mg of rezafungin weekly for 26 weeks after unsatisfactory results with voriconazole and liposomal amphotericin B.
  • Rezafungin demonstrates a promising alternative for treating Candida-related osteomyelitis, especially in cases where standard therapies fail or are poorly tolerated, with the patient showing full recovery without side effects.
View Article and Find Full Text PDF

Campania is the sixth poorest region of Italy, and it is the region with the highest income inequality. The secondary attack rates of SARS-CoV-2 among households are found to be substantially heterogeneous among published studies and are influenced by socio-economic factors. We conducted a retrospective study to describe the role of socio-economic factors in the household transmission of SARS-CoV-2 among patients living in Campania Region and referring to "Federico II" Hospital.

View Article and Find Full Text PDF